Clinical trial
Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
NCT00721370 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- January 31, 2011
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer